Healthcare & Biotech

Miami – September 29, 2026 -- eMed, a digital healthcare company, and The Female Quotient, a global media and experiences firm reaching over 8 million leaders across 30 industries, have announced a strategic partnership targeting a $1 trillion annual opportunity in the global economy by 2040 tied to closing the women's health gap.

Partnership launches at New York summit on October 14

The collaboration will officially debut at the FQ Health Summit in New York City, where executives will discuss innovation to address disparities in women's healthcare access. Chloe Ferro and Olivia Ferro, founders of sheMed, will join the discussion to share perspectives on personalized care.

Nashville, Tenn. – – September 29, 2026 -- Thyme Companies has appointed Carolyn Starrett as executive vice president of new ventures, tasking her with identifying and scaling new businesses beyond its existing Thyme Care platform. Starrett reports directly to Executive Chairman Robin Shah, marking her second collaboration with him after their tenure together at Flatiron Health.

Starrett brings a decade of oncology data leadership from Flatiron Health

Starrett joined Flatiron Health in 2016 alongside Thyme's founders and served as its Chief Executive Officer from 2021 to 2025. Under her leadership, Flatiron's real-world evidence platform expanded from roughly 400,000 to more than 5.5 million patient records. Its OncoEMR platform grew to serve more than 4,500 oncology providers nationwide, while the company extended research operations into the United Kingdom, Germany and Japan.

Atlanta – September 29, 2026 -- The Jack & Jill Late Stage Cancer Foundation (JAJF) has completed 20 years of funding fully-paid family trips for parents with terminal cancer diagnoses, a model now formally prescribed by oncologists across the United States as part of patient treatment protocols.

Foundation traces origin to a 2006 family diagnosis

Jon Albert founded JAJF in 2006 after his wife, Jill, was diagnosed with Stage IV metastatic breast cancer. Jill died two weeks after the foundation's launch, but the organization she inspired has since delivered what it calls WOW! Experiences to thousands of children and parents nationwide.

Ann Arbor – September 29, 2026 -- Truven has launched MarketScan Snapshot, an AI-powered search capability that compresses what the company says can be days or weeks of cohort feasibility research into a process taking minutes.

Snapshot lets researchers query 300 million cumulative patient lives in plain language

The tool allows users to run patient-count requests against MarketScan Research Databases using everyday language, eliminating the need to specify medical codes or possess programming skills. MarketScan's underlying dataset includes more than 300 million cumulative lives, 95 million active lives, 99% claims completeness, and data access dating back to 1995 across commercial, Medicare and Medicaid populations.

Campbell, Calif. – September 29, 2026 -- Vivalink, a digital healthcare solutions provider, published survey data showing 79% of more than 150 U.S. adults with cardiac conditions would participate in a home-based cardiac rehabilitation program if recommended by a provider.

Patients favor hybrid or home-based rehab over clinic visits

When given a choice, 68% of respondents said they would prefer a primarily home-based or hybrid rehabilitation approach over traditional in-clinic programs.

Insurance coverage ranks as the top barrier to participation

Fifty-eight percent of respondents ranked insurance coverage as their top consideration for participating in home-based care. Sixty percent said they would not pay out of pocket for such a program, while 87% said confirmed insurance coverage would increase their likelihood of participating.

New York – September 29, 2026 -- 120/80 Health Group has logged its eighth consecutive year of record growth, fueled by new client wins and deepening relationships across healthcare and life sciences.

Top-10 biopharma and diagnostic firms sign on for AI-driven work

The firm added multiple category-leading clients in 2026 and began working with several top-10 global biopharmaceutical and diagnostic companies applying AI to drug, test and device development. The agency has shifted from brand-awareness communications for early-stage digital health startups to a strategic consultancy serving businesses from pre-Series A through publicly traded companies.

New York – – September 29, 2026 -- Deloitte analysis projects that shifting U.S. healthcare from reactive treatment to proactive, life-stage-aware care could generate $527 billion in additional potential spending on women's health by 2030 compared with a baseline trajectory.

Deloitte models a 20-year health span gain from earlier intervention

Under a prevention and improved disease-management scenario, Deloitte's actuarial Future of Health model — built on five years of medical and pharmacy claims data from nearly 60 million lives — estimates women's health span could increase by up to 20 years in the long run. The firm's report, "How a $527 billion growth opportunity in women's health can improve health outcomes," compares a baseline 2030 spending trajectory against a scenario emphasizing earlier detection and management across 22 disease states.

Linköping – – September 29, 2026 -- Swedish medical imaging IT firm Sectra (STO: SECT B) has signed a partner agreement with S&S Partners to enter Brazil, Latin America's largest healthcare market, with an initial focus on its cloud-based enterprise imaging platform Sectra One Cloud.

Brazil's 7,100 hospitals drive shift from on-premise to cloud imaging

Brazil operates approximately 7,100 hospitals, with the private sector accounting for the majority of advanced imaging investment. Major private hospital groups are pushing the market away from on-premise capital purchases toward subscription-based cloud platforms, a shift Sectra says is already gaining momentum.

Torbjörn Kronander, President and CEO at Sectra, said the partnership with S&S Partners provides access to the relationships and local market knowledge required for entry into Brazil.

London – September 29, 2026 -- JOE Media Group has launched a heart-health awareness campaign built around a Viking folk character named Jordic, using erectile dysfunction (ED) as an entry point to warn men about underlying cardiovascular disease risk.

Campaign ties ED symptoms to a two-to-five-year cardiovascular warning window

The 'Listen to Jordic' campaign, created by Havas Lynx UK for JOE Media Group, launched on World Heart Day exclusively on JOE.co.uk. Medical literature cited in the campaign indicates ED can precede cardiovascular symptoms by two to five years, offering a critical window for men to seek diagnosis.

Los Angeles – – September 29, 2026 -- Congress has passed the Accelerating Access to Critical Therapies (ACT) for ALS Reauthorization Act of 2026 (H.R. 8205), sending the bipartisan bill to the President's desk just two days before the underlying program was set to expire on September 30, 2026.

Senate approval follows House passage, clearing the path for a presidential signature

The legislation cleared the U.S. House of Representatives before the Senate gave final approval, moving the bill to the President for signature. Once enacted, the law will extend core ACT for ALS programs through 2031, continuing federal support for ALS research infrastructure and expanded access to investigational therapies.